StonvexLoading…
StonvexStonvexStonvexCore line items from ONDS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $50.73M | $7.19M | $15.69M | $2.13M |
Operating Income | $-58.38M | $-34.61M | $-39.73M | $-69.43M |
Net Income | $-132.24M | $-38.01M | $-44.84M | $-73.24M |
EPS (Diluted) | $-0.62 | $-0.61 | $-0.88 | $-1.73 |
Total Assets | $1.13B | $109.62M | $92.16M | $97.95M |
Total Liabilities | $661.23M | $73.68M | $47.11M | $39.72M |
Cash & Equivalents | $550.74M | $29.96M | $15.02M | $29.78M |
Free Cash Flow OCF − CapEx | $-40.78M | $-35.10M | $-34.23M | $-40.84M |
Shares Outstanding | 380.76M | 93.17M | 61.94M | 44.11M |